Abstract
Mycosis fungoides (MF) is the most frequent cutaneous T-cell lymphoma in 60% to 65% of all cases. The incidence reported in Mexico is 0.14% per year.1 It affects generally male gender with a ratio 1.6:1 in their fifth decade.2 Most patients are diagnosed in the early stage of disease. First-line treatment of early-stage disease consists of skin-directed therapies. This study aimed to determine prognostic factors for disease remission in early-stage MF.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
